Company GeneOne Life Science, Inc.

Equities

A011000

KR7011000007

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 03:30:00 03/05/2024 am IST			5-day change	1st Jan Change
2,405 ^KRW	-0.82%		+1.26%	-15.32%

28/03	GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	CI
27/03	GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

GeneOneLifeScience, formerly VGX International, Inc., is a Korea-based company engaged in textile and biopharmaceutical businesses. The Company is a biomedical contract manufacturing organization (CMO). Its textile business engages in the provision of wicks under the brand name of INTERON, which are used in dress shirts, suits and caps. Its biopharmaceutical business engages in the research, development and manufacture of biomedical, plasmid deoxyribonucleic acid (DNA) and DNA vaccines. It also engaged in the leasing of nonresidential buildings.

Number of employees: 75

KRW in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 68.3 %	32,840	67.4 %	27,454	68.3 %	-16.40%
Fabric 31.7 %	15,878	32.6 %	12,749	31.7 %	-19.71%

KRW in Million	2022	Weight	2023	Weight	Delta
Overseas 89.7 %	44,180	90.7 %	36,077	89.7 %	-18.34%
South Korea 10.3 %	4,538	9.3 %	4,126	10.3 %	-9.09%

Managers	Title	Age	Since
Young-Geun Park CEO	Chief Executive Officer	60	-
Won-Il Kim CTO	Chief Tech/Sci/R&D Officer	52	-
Byung-Moon Cho BRD	Director/Board Member	64	-
Jae-Kyung Chae PRN	Corporate Officer/Principal	55	-
Seong-Ho Choi AUD	Comptroller/Controller/Auditor	61	-

Members of the board	Title	Age	Since
Byung-Moon Cho BRD	Director/Board Member	64	-
Young-Geun Park CEO	Chief Executive Officer	60	-
Sang-Don Kim BRD	Director/Board Member	58	31/20/31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	78,473,817	71,452,301 ( 91.05 %)	209,464 ( 0.2669 %)	91.05 %

Name	Equities	%	Valuation
Young-Geun Park 8.539 %	6,700,873	8.539 %	13 M ₩
Byung-Moon Cho 1.131 %	887,926	1.131 %	2 M ₩
Edward Chung 0.6249 %	490,363	0.6249 %	923 358 ₩
GENEONE LIFE SCIENCE, INC. 0.2669 %	209,464	0.2669 %	394 423 ₩
Jae-Kyung Chae 0.1731 %	135,817	0.1731 %	255 745 ₩
Seong-Ho Choi 0.1101 %	86,414	0.1101 %	162 718 ₩
Dimensional Fund Advisors Ltd. 0.006019 %	4,723	0.006019 %	8 893 ₩
DFA Australia Ltd. 0.003183 %	2,498	0.003183 %	4 704 ₩
Mirae Asset Global Investments Co., Ltd. 0.001288 %	1,011	0.001288 %	1 904 ₩
Korea Investment Management Co., Ltd. 0.000344 %	270	0.000344 %	508 ₩

Name	Equities	%	Valuation
GENEONE LIFE SCIENCE, INC. 0.27%	209,464	0.27%	394,423 $

GeneOne Life Science, Inc.

20th Floor, Park1 NH Financial Tower 108 Yeoui-daero

07335, Seoul

http://www.genels.com

address GeneOne Life Science, Inc.(A011000)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENEONE LIFE SCIENCE, INC.	-15.32%	142M
MODERNA, INC.	+25.69%	47.9B
LONZA GROUP AG	+46.90%	41.42B
IQVIA HOLDINGS INC.	-3.46%	40.7B
CELLTRION, INC.	-6.20%	28.92B
ICON PUBLIC LIMITED COMPANY	+9.17%	25.55B
ALNYLAM PHARMACEUTICALS, INC.	-20.42%	19.27B
BIO-TECHNE CORPORATION	+0.17%	12.15B
MEDPACE HOLDINGS, INC.	+28.07%	12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.24%	11.99B

Other Biotechnology & Medical Research